PULMOPHARMA ApS: Financial statements 2025
CVR: 36428023
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
PULMOPHARMA ApS (CVR 36428023) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -49,353 and a net result of DKK -49,353 compared with DKK -20,499 the year before. Equity in the 2025 report amounted to DKK 11,436,934. The solvency ratio was 84.2%.
- Gross Profit
- DKK -49,353
- Profit/Loss
- DKK -49,353
- Equity
- DKK 11,436,934
- Total Assets
- DKK 13,581,786
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -49 t. | -49 t. | 11.4 mio. | 0 |
| 2024 | - | -20 t. | -20 t. | 7.4 mio. | 0 |
| 2023 | - | -47 t. | -47 t. | 7.4 mio. | 0 |
| 2022 | - | -56 t. | -63 t. | 3.4 mio. | 0 |
| 2021 | - | -80 t. | -93 t. | 3.5 mio. | 0 |
Official annual report
How creditworthy is PULMOPHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
PULMOPHARMA ApS has published its annual report for 2024. Gross profit came to DKK -20,499, and the net result was DKK -20,499.
As of March 27, 2025, LARS NYENSTAD ApS is registered as an owner of PULMOPHARMA ApS with an ownership share of 20%.
As of March 27, 2025, BENDIX-HOLDING ApS is registered as an owner of PULMOPHARMA ApS with an ownership share of 20%.
As of March 27, 2025, LouMar ApS is registered as an owner of PULMOPHARMA ApS with an ownership share of 20%.
About PULMOPHARMA ApS
PULMOPHARMA ApS is a Danish company of the type Anpartsselskab based in Ebeltoft, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named PULMOPHARMA IVS. The management consists of Dan Mønster Nielsen. The board consists of Torben Ballegaard Sørensen (chair), Dan Mønster Nielsen, Per Bendix Jeppesen and Peter Frithjof Bang. The company's owners include PETER BANG HOLDING ApS, LARS NYENSTAD ApS and BENDIX-HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -49,353 and a net result of DKK -49,353 compared with DKK -20,499 the year before. Equity in the 2025 report amounted to DKK 11,436,934.